Antiplatelet therapy: thrombin receptor antagonists.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 658, doi. 10.1111/j.1365-2125.2010.03884.x
- By:
- Publication type:
- Article
Works matching IS 03065251 AND DT 2011 AND VI 72 AND IP 4
Results: 21
1
2
On the dosing of lepirudin.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 717, doi. 10.1111/j.1365-2125.2011.04073.x
- By:
- Publication type:
- Article
3
Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 553, doi. 10.1111/j.1365-2125.2010.03899.x
- By:
- Publication type:
- Article
4
Inhibitors of the initiation of coagulation.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 547, doi. 10.1111/j.1365-2125.2011.03960.x
- By:
- Publication type:
- Article
5
Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 604, doi. 10.1111/j.1365-2125.2011.03906.x
- By:
- Publication type:
- Article
6
The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 707, doi. 10.1111/j.1365-2125.2011.03957.x
- By:
- Publication type:
- Article
7
Introduction to haemostasis from a pharmacodynamic perspective.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 538, doi. 10.1111/j.1365-2125.2011.03946.x
- By:
- Publication type:
- Article
8
Translation Section.
- Published in:
- 2011
- Publication type:
- Other
9
Direct thrombin inhibitors.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 581, doi. 10.1111/j.1365-2125.2011.03916.x
- By:
- Publication type:
- Article
10
New anticoagulants: how to deal with treatment failure and bleeding complications.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 593, doi. 10.1111/j.1365-2125.2011.04060.x
- By:
- Publication type:
- Article
11
Anticoagulants, Antiplatelets and Thrombolytics, 2nd Edition.
- Published in:
- 2011
- By:
- Publication type:
- Book Review
12
Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 697, doi. 10.1111/j.1365-2125.2011.03949.x
- By:
- Publication type:
- Article
13
Anti-platelet therapy: glycoprotein IIb-IIIa antagonists.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 672, doi. 10.1111/j.1365-2125.2010.03879.x
- By:
- Publication type:
- Article
14
To bleed or not to bleed. Is that the question?
- Published in:
- 2011
- By:
- Publication type:
- Editorial
15
Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 683, doi. 10.1111/j.1365-2125.2011.03955.x
- By:
- Publication type:
- Article
16
Inhibitors of propagation of coagulation: factors V and X.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 563, doi. 10.1111/j.1365-2125.2011.04001.x
- By:
- Publication type:
- Article
17
Anti-platelet therapy: ADP receptor antagonists.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 647, doi. 10.1111/j.1365-2125.2011.03999.x
- By:
- Publication type:
- Article
18
Anti-platelet therapy: phosphodiesterase inhibitors.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 634, doi. 10.1111/j.1365-2125.2011.04034.x
- By:
- Publication type:
- Article
19
Correction to lepirudin dosage in table 1 of 'Direct Thrombin Inhibitors'.
- Published in:
- 2011
- By:
- Publication type:
- Letter
20
Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 619, doi. 10.1111/j.1365-2125.2011.03943.x
- By:
- Publication type:
- Article
21
Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 4, p. 715, doi. 10.1111/j.1365-2125.2011.03965.x
- By:
- Publication type:
- Article